Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Equity / COM CL A NEW
-
Number of holders
-
14
-
Total 13F shares, excl. options
-
293K
-
Shares change
-
+202K
-
Total reported value, excl. options
-
$1.84M
-
Value change
-
+$1.83M
-
Number of buys
-
13
-
Number of sells
-
-1
-
Price
-
$6.30
Significant Holders of P3 Health Partners Inc. - COM CL A NEW (PIII) as of Q2 2025
15 filings reported holding PIII - P3 Health Partners Inc. - COM CL A NEW as of Q2 2025.
P3 Health Partners Inc. - COM CL A NEW (PIII) has 14 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 293K shares
.
Largest 10 shareholders include Alyeska Investment Group, L.P. (181K shares), VANGUARD GROUP INC (38.4K shares), Corient Private Wealth LLC (35.4K shares), GEODE CAPITAL MANAGEMENT, LLC (20.2K shares), BlackRock, Inc. (10.6K shares), BLAIR WILLIAM & CO/IL (2.43K shares), UBS Group AG (1.61K shares), PNC Financial Services Group, Inc. (1.37K shares), JPMORGAN CHASE & CO (1.02K shares), and MORGAN STANLEY (360 shares).
This table shows the top 14 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.